Drugs Made In America Acquisition Corp. Units (DMAAU) — Cash Flow Quality Index
Drugs Made In America Acquisition Corp. Units (DMAAU) has a Cash Flow Quality Index of -0.59x as of December 2025. Operating cash flow of $-125.18K is below net income of $212.96K, suggesting accrual-heavy earnings not yet converted to cash. Also explore Drugs Made In America Acquisition Corp. total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Drugs Made In America Acquisition Corp. Units Cash Flow Quality Index (2025–2025)
Historical Cash Flow Quality Index for Drugs Made In America Acquisition Corp. Units across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check DMAAU goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Drugs Made In America Acquisition Corp. Units (2025–2025)
Year-by-year earnings quality comparison for Drugs Made In America Acquisition Corp. Units. For live market cap and the full company financial profile, see DMAAU market cap overview.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.14x | $-539.19K | $3.97 Million | — |